Triple Therapy Shows Promise for Treating Cystic Fibrosis in Young Children

Just now September 26, 2026 1 min read 📰 Medical Xpress

📋 Key Takeaway

Researchers at Charité – Universitätsmedizin Berlin have found that a treatment called triple therapy for cystic fibrosis is particularly effective in early childhood, improving the function of molecular channels in children aged 2 to 11. This advancement in treatment could have implications for healthcare in Iran, especially for families affected by this genetic disorder.

Cystic fibrosis is an incurable genetic disorder. Since 2020, a treatment known as triple therapy has addressed the underlying cause. Researchers at Charité – Universitätsmedizin Berlin found that the therapy is particularly effective in early childhood: Molecular channels in the mucous membranes, which do not function or function poorly in people with cystic fibrosis, reached nearly normal functional levels in children ages 2 to 11 following treatment.